Novel Gd-DTPA-peptide for targeted breast tumor magnetic resonance imaging

The prevalence of breast cancer underscores the imperative for early diagnosis in guiding treatment decisions. This study introduces a novel contrast agent, Gd-DTPA-VGB3, derived from the peptide VGB3 targeting vascular endothelial growth factor receptor-1 (VEGFR1) and VEGFR2, to enhance the contras...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2024-09, Vol.178, p.117189, Article 117189
Hauptverfasser:	Reisi Zargari, Nooshin, Ebrahimi, Fatemeh, Akhlaghi, Mehdi, Beiki, Davood, Abdi, Khosrou, Abbasi, Mohammad Amin, Ramezanpour, Sorour, Asghari, S. Mohsen
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer MRI contrast enhancement Peptide Tumor Targeting VEGFR1/2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!